McMaster University

McMaster University

Faculty of
Health Sciences

McMaster researcher receives Movember Discovery Grant

Published: July 18, 2013
Khalid Al-Nedawi
Khalid Al-Nedawi, a researcher in the Department of Medicine

A McMaster researcher testing a promising new biomarker for diagnosing prostate cancer, has received the grant from funds raised during Movember.

Khalid Al-Nedawi, a researcher in the Department of Medicine, is assessing the potential of the biomarker to discriminate prostate cancer patients from normal subjects; its ability to predict the metastasis of prostate cancer; and its ability to discriminate prostate cancer from non-cancerous prostate conditions that cause elevated prostate-specific antigen.

For decades, the standard biomarker for prostate cancer diagnosis was prostate specific antigen (PSA) and many studies have confirmed it can’t discriminate between benign and life-threatening tumors. This leads to a large number of unnecessary biopsies and the overtreatment of low-risk patients, he said.

Al-Nedwai is among 40 grant recipients across Canada funded by the Prostate Cancer Canada. Each recipient of the Movember Discovery Grants will receive up to $200,000 in funding over a two-year term. Men raise funds by growing mustaches during the annual Movember fundraising drive.

The grants are for innovation in prostate cancer research and focus on a broad range of topics, from basic biological science to population health.

Valid XHTML 1.0 Transitional Level Double-A conformance, W3C WAI Web Content Accessibility Guidelines 2.0